FARPCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。FARP遺伝子サイレンサーは、FARP CRISPR/Cas9ノックアウトプラスミドとFARPDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のFARPCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
FARP CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
FARP1 CRISPR/Cas9 KOプラスミド (h) | sc-402352 | h | Gene Knockout | GFP | 0 | ||
FARP1 HDRプラスミド (h) | sc-402352-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FARP1 Double Nickaseプラスミド (h) | sc-402352-NIC | h | Gene Knockout | Puromycin | 0 | ||
FARP1 Double Nickaseプラスミド (h2) | sc-402352-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FARP1 CRISPR/Cas9 KOプラスミド (m) | sc-432359 | m | Gene Knockout | GFP | 0 | ||
FARP1 HDRプラスミド (m) | sc-432359-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FARP1 Double Nickaseプラスミド (m) | sc-432359-NIC | m | Gene Knockout | Puromycin | 0 | ||
FARP1 Double Nickaseプラスミド (m2) | sc-432359-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
FARP2 CRISPR/Cas9 KOプラスミド (h) | sc-411366 | h | Gene Knockout | GFP | 0 | ||
FARP2 HDRプラスミド (h) | sc-411366-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FARP2 Double Nickaseプラスミド (h) | sc-411366-NIC | h | Gene Knockout | Puromycin | 0 | ||
FARP2 Double Nickaseプラスミド (h2) | sc-411366-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FARP2 CRISPR/Cas9 KOプラスミド (m) | sc-432696 | m | Gene Knockout | GFP | 0 | ||
FARP2 HDRプラスミド (m) | sc-432696-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FARP2 Double Nickaseプラスミド (m) | sc-432696-NIC | m | Gene Knockout | Puromycin | 0 | ||
FARP2 Double Nickaseプラスミド (m2) | sc-432696-NIC-2 | m | Gene Knockout | Puromycin | 0 |
FARP CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
FARP1 CRISPR Activationプラスミド (h) | sc-402352-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 CRISPR Activationプラスミド (h2) | sc-402352-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (h) | sc-402352-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (h2) | sc-402352-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 CRISPR Activationプラスミド (m) | sc-432359-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 CRISPR Activationプラスミド (m2) | sc-432359-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (m) | sc-432359-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (m2) | sc-432359-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activationプラスミド (h) | sc-411366-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activationプラスミド (h2) | sc-411366-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (h) | sc-411366-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (h2) | sc-411366-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activationプラスミド (m) | sc-432696-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activationプラスミド (m2) | sc-432696-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (m) | sc-432696-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (m2) | sc-432696-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |